These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3657151)

  • 1. Analysis of tamoxifen and 4-hydroxytamoxifen levels in immature rat uterine cytoplasm and KCl-nuclear extracts by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).
    Murphy C; Fotsis T; Adlercreutz H; Martin F
    J Steroid Biochem; 1987 Sep; 28(3):289-99. PubMed ID: 3657151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen levels in cytosol and KCl-nuclear extracts of breast tumours from tamoxifen treated patients by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).
    Murphy C; Fotsis T; Pantzar P; Adlercreutz H; Martin F
    J Steroid Biochem; 1987 Dec; 28(6):609-18. PubMed ID: 3695512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat.
    Bowman SP; Leake A; Morris ID
    J Endocrinol; 1982 Aug; 94(2):167-75. PubMed ID: 7108408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).
    Murphy C; Fotsis T; Pantzar P; Adlercreutz H; Martin F
    J Steroid Biochem; 1987 May; 26(5):547-55. PubMed ID: 3586671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
    Robinson SP; Langan-Fahey SM; Johnson DA; Jordan VC
    Drug Metab Dispos; 1991; 19(1):36-43. PubMed ID: 1673419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo binding of toremifene and its metabolites in rat uterus.
    Simberg NH; Murai JT; Siiteri PK
    J Steroid Biochem; 1990 Jun; 36(3):197-202. PubMed ID: 2142232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
    Daniel CP; Gaskell SJ; Nicholson RI
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.
    Borgna JL; Rochefort H
    J Biol Chem; 1981 Jan; 256(2):859-68. PubMed ID: 7451477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and biological activity of tamoxifen metabolites in human serum.
    Kemp JV; Adam HK; Wakeling AE; Slater R
    Biochem Pharmacol; 1983 Jul; 32(13):2045-52. PubMed ID: 6870933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Campen CA; Jordan VC; Gorski J
    Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
    Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
    Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Poon GK
    Cancer Res; 1994 Nov; 54(21):5518-22. PubMed ID: 7923188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen metabolism in rat liver microsomes: identification of a dimeric metabolite derived from free radical intermediates by liquid chromatography/mass spectrometry.
    Jones RM; Yuan ZX; Lim CK
    Rapid Commun Mass Spectrom; 1999; 13(4):211-5. PubMed ID: 10097399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
    Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
    Boocock DJ; Maggs JL; White IN; Park BK
    Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues.
    Brown K; Brown JE; Martin EA; Smith LL; White IN
    Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effects of Hedyotis diffusa extract on the pharmacokinetics of tamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen.
    Cheng YY; Tuzo ET; Dalley JW; Tsai TH
    Biomed Pharmacother; 2022 Jan; 145():112466. PubMed ID: 34839255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.